Sanlam Kenya Plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Sanlam Kenya Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4029
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ケニア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanlam Kenya Plc – Strategy, SWOT and Corporate Finance Report
Summary

Sanlam Kenya Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanlam Kenya Plc (Sanlam Kenya), a subsidiary of Hubris Holdings Limited, is an insurance holding company. The company along with its subsidiaries offers a range of life and non-life insurance and investment products. The life insurance products offered by the company include pension plans, annuity plans, savings plans, endowment policies, group mortgage plans, group last expense insurance, and group credit assurance policies. Its general insurance product portfolio includes motor insurance, home insurance, business interruption plans, group personal accident insurance, product liability insurance, marine insurance, construction all risk insurance, fire and perils insurance, and electronic equipment insurance. Sanlam Kenya also provides asset management, treasury management, and claims related services. The company caters to individuals, high net worth individuals, corporate, and institutions through a network of agents, brokers and branches in Kenya. Sanlam Kenya is headquartered in Nairobi, Kenya.

The company reported gross premium income of KES5,224.5 million during the fiscal year ended December 2016 (FY2016), an increase of 0.8% over FY2015. Its net premium income stood at KES4,832.2 million in FY2016, an increase of 0.7% over FY2015.

Scope

- Detailed information on Sanlam Kenya Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanlam Kenya Plc in the form of a SWOT analysis
- An in-depth view of the business model of Sanlam Kenya Plc including a breakdown and examination of key business segments
- Intelligence on Sanlam Kenya Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanlam Kenya Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanlam Kenya Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanlam Kenya Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanlam Kenya Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sanlam Kenya Plc: Company Overview 9
Sanlam Kenya Plc: Overview and Key Facts 9
Sanlam Kenya Plc: Overview 9
Sanlam Kenya Plc: Key Facts 9
Sanlam Kenya Plc: Key Employees 11
Sanlam Kenya Plc: Key Employee Biographies 12
Sanlam Kenya Plc: Major Products and Services 13
Sanlam Kenya Plc: Company History 14
Sanlam Kenya Plc: Management Statement 16
Sanlam Kenya Plc: Locations and Subsidiaries 20
Sanlam Kenya Plc: Key Competitors 21
Sanlam Kenya Plc: Company Analysis 22
Sanlam Kenya Plc: Business Description 22
Sanlam Kenya Plc: SWOT Analysis 23
Sanlam Kenya Plc: SWOT Overview 23
Sanlam Kenya Plc: Strengths 23
Sanlam Kenya Plc: Weaknesses 24
Sanlam Kenya Plc: Opportunities 24
Sanlam Kenya Plc: Threats 24
Sanlam Kenya Plc: Corporate Financial Deals Activity 26
Sanlam Kenya Plc: Financial Deals Overview 26
Sanlam Kenya Plc: Targets and Partners 27
Sanlam Kenya Plc: Top Deals 2014 – 2018YTD* 28
Sanlam Kenya Plc: Mergers and Acquisitions 29
Sanlam Kenya Plc: Recent Developments 30
Sanlam Kenya Plc: News and Events Summary 30
Sanlam Kenya Plc: Business Expansion 32
Sanlam Kenya Plc: Corporate Governance 33
Sanlam Kenya Plc: Strategy and Operations 34
Appendix 36
Contact Us 36
Methodology 36
About MarketLine 37

List of Tables
Table 1: Sanlam Kenya Plc: Key Facts
Table 2: Sanlam Kenya Plc: Key Employees
Table 3: Sanlam Kenya Plc: Locations and Subsidiaries
Table 4: Sanlam Kenya Plc: Key Competitors
Table 5: Sanlam Kenya Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Sanlam Kenya Plc: Targets and Partners
Table 7: Sanlam Kenya Plc: Top Deals 2014 - 2018YTD*
Table 8: Sanlam Kenya Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 9: Sanlam Kenya Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 10: Sanlam Kenya Plc: News and Events Summary
Table 11: Sanlam Kenya Plc: Business Expansion
Table 12: Sanlam Kenya Plc: Corporate Governance
Table 13: Sanlam Kenya Plc: Strategy and Operations

List of Figures
Figure 1: Sanlam Kenya Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Sanlam Kenya Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Sanlam Kenya Plc: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[Sanlam Kenya Plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • Bank Sohar SAOG (BKSB):企業の財務・戦略的SWOT分析
    Bank Sohar SAOG (BKSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • iPass Inc. (IPAS):企業の財務・戦略的SWOT分析
    iPass Inc. (IPAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務情報
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Vectura Group Plc (VEC)-医療機器分野:企業M&A・提携分析
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and p …
  • Consumers Energy Company-エネルギー分野:企業M&A・提携分析
    Summary Consumers Energy Company (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates …
  • PLC SPA (IIN):電力:M&Aディール及び事業提携情報
    Summary PLC SPA (PLC Group) formerly Industria e Innovazione S.p.A, is a provider of design, installation, and maintenance services for electrical infrastructures and renewable energy plants. The company’s service offerings include engineering, procurement, and construction (EPC); manufacturing and …
  • Kleemann Hellas SA:企業の戦略・SWOT・財務情報
    Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report Summary Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Wilson Therapeutics AB (WTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The company’s lead product includes WTX101 is a copper-protein-binding agent, which is used …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • Takeda Pharmaceutical Co Ltd (4502):製薬・医療:M&Aディール及び事業提携情報
    Summary Takeda Pharmaceutical Company Ltd (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • LMI Aerospace, Inc.:企業の戦略・SWOT・財務情報
    LMI Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary LMI Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Storebrand ASA:企業のM&A・事業提携・投資動向
    Storebrand ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Storebrand ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • SunOpta Inc.:企業のM&A・事業提携・投資動向
    SunOpta Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SunOpta Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆